Simultaneous high-performance liquid chromatographic assay for quinidine, disopyramide and the mono-N-dealkylated metabolite of disopyramide
Authors:
- Ross L.G. NorrisRNRoss L.G. Norris
- Jorma T. AhokasJAJorma T. Ahokas
- Peter J. RavenscroftPRPeter J. Ravenscroft
- 9 July 1982
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 230 (2) , 433-437
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Plasma concentrations and protein binding of disopyramide and mono‐N‐ dealkyldisopyramide during chronic oral disopyramide therapy.British Journal of Clinical Pharmacology, 1981
- Simultaneous analysis of disopyramide and quinidine in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Impact of Active Metabolites on Monitoring Plasma Concentrations of Therapeutic DrugsTherapeutic Drug Monitoring, 1980
- Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscleEuropean Journal of Pharmacology, 1978
- Comparative evaluation of procainamide and its main metabolite, N- acetylprocainamide, in the acute treatment of ventricular arrhythmias [proceedings]1977
- PLASMA CONCENTRATION OF AMITRIPTYLINE AND CLINICAL RESPONSEThe Lancet, 1972